Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Hess

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
The Patient|October 17, 2016
The Patient Experience with Soft Tissue Sarcoma: A Systematic Review of the LiteratureRandall Winnette, Lisa M Hess, Steven J Nicol, et al.
Current Medical Research and Opinion|December 18, 2020
Treatment sequencing for the care of patients with advanced or metastatic non-small cell lung cancer in the United StatesLisa M Hess, Zhanglin Lin Cui, Xiaohong Ivy Li, et al.
Journal of Gastric Cancer|July 11, 2015
Treatment Patterns, Costs, and Survival among Medicare-Enrolled Elderly Patients Diagnosed with Advanced Stage Gastric Cancer: Analysis of a Linked Population-Based Cancer Registry and Administrative Claims DatabaseSudeep Karve, Maria Lorenzo, Astra M Liepa, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 3, 2018
Predictors of heterogeneity in the first-line treatment of patients with advanced/metastatic gastric cancer in the U.SThomas Abrams, Lisa M Hess, Yajun Emily Zhu, et al.
International Journal of Colorectal Disease|January 10, 2019
Treatment patterns and survival outcomes for patients receiving second-line treatment for metastatic colorectal cancer in the USALisa M Hess, Zhanglin Lin Cui, Daniel S Mytelka, et al.
Journal of Managed Care & Specialty Pharmacy|May 23, 2017
Factors Associated with Adherence to and Treatment Duration of Erlotinib Among Patients with Non-Small Cell Lung CancerLisa M Hess, Anthony Louder, Katherine Winfree, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 21, 2015
Chemotherapy treatment patterns, costs, and outcomes of patients with gastric cancer in the United States: a retrospective analysis of electronic medical record (EMR) and administrative claims dataLisa M Hess, Diane Michael, Daniel S Mytelka, et al.
Hematology (Amsterdam, Netherlands)|February 6, 2025
Clinical trial participation, clinical care, and patient outcomes by practice setting: a real-world database analysis of patients with Chronic Lymphocytic Leukemia or Mantle Cell LymphomaDebora S Bruno, Manoj Khanal, Xiaohong Li, et al.
Cancer Treatment and Research Communications|September 17, 2023
Initial versus early switch to targeted therapy during first-line treatment among patients with biomarker-positive advanced or metastatic non-small cell lung cancer in the United StatesLisa M Hess, Patrick Peterson, Tomoko Sugihara, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 15, 2005
Adherence assessment using medication weight in a phase IIb clinical trial of difluoromethylornithine for the chemoprevention of skin cancerLisa M Hess, Kathylynn Saboda, Daniel C Malone, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
The Patient|October 17, 2016
The Patient Experience with Soft Tissue Sarcoma: A Systematic Review of the LiteratureRandall Winnette, Lisa M Hess, Steven J Nicol, et al.
Current Medical Research and Opinion|December 18, 2020
Treatment sequencing for the care of patients with advanced or metastatic non-small cell lung cancer in the United StatesLisa M Hess, Zhanglin Lin Cui, Xiaohong Ivy Li, et al.
Journal of Gastric Cancer|July 11, 2015
Treatment Patterns, Costs, and Survival among Medicare-Enrolled Elderly Patients Diagnosed with Advanced Stage Gastric Cancer: Analysis of a Linked Population-Based Cancer Registry and Administrative Claims DatabaseSudeep Karve, Maria Lorenzo, Astra M Liepa, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 3, 2018
Predictors of heterogeneity in the first-line treatment of patients with advanced/metastatic gastric cancer in the U.SThomas Abrams, Lisa M Hess, Yajun Emily Zhu, et al.
International Journal of Colorectal Disease|January 10, 2019
Treatment patterns and survival outcomes for patients receiving second-line treatment for metastatic colorectal cancer in the USALisa M Hess, Zhanglin Lin Cui, Daniel S Mytelka, et al.
Journal of Managed Care & Specialty Pharmacy|May 23, 2017
Factors Associated with Adherence to and Treatment Duration of Erlotinib Among Patients with Non-Small Cell Lung CancerLisa M Hess, Anthony Louder, Katherine Winfree, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 21, 2015
Chemotherapy treatment patterns, costs, and outcomes of patients with gastric cancer in the United States: a retrospective analysis of electronic medical record (EMR) and administrative claims dataLisa M Hess, Diane Michael, Daniel S Mytelka, et al.
Hematology (Amsterdam, Netherlands)|February 6, 2025
Clinical trial participation, clinical care, and patient outcomes by practice setting: a real-world database analysis of patients with Chronic Lymphocytic Leukemia or Mantle Cell LymphomaDebora S Bruno, Manoj Khanal, Xiaohong Li, et al.
Cancer Treatment and Research Communications|September 17, 2023
Initial versus early switch to targeted therapy during first-line treatment among patients with biomarker-positive advanced or metastatic non-small cell lung cancer in the United StatesLisa M Hess, Patrick Peterson, Tomoko Sugihara, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 15, 2005
Adherence assessment using medication weight in a phase IIb clinical trial of difluoromethylornithine for the chemoprevention of skin cancerLisa M Hess, Kathylynn Saboda, Daniel C Malone, et al.
Pageof 11